NAPP PHARMACEUTICAL HOLDINGS LIMITED
Company Information
- Company Number
- 03486244
- Registered Address
- Unit 196 Cambridge Science Park, Milton Road, Cambridge, England, CB4 0AB
- Status
- Active
- Employee Count
- 372.0
- Turnover
- 206557000.0
- EBITDA
- 67344000.0
Additional Details
- Website
- https://napp.co.uk/
- Company Type
- Private limited Company
- Incorporated On
- 19 December 1997
- Nature of Business
- 21200 - Manufacture of pharmaceutical preparations$46460 - Wholesale of pharmaceutical goods
- Industries
- Life Sciences And Medical Technology,Supply Chain,Manufacturing And Commerce Models
- Region
- East of England
Company Location
Loading map...
Financial Metrics
Time to Pay
Payment Timeline
Payment Features
Payment Time Trends
Payment Distribution Trends
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2023 - 31 Dec 2023 | 31 Jan 2024 | 34 | 57% | 30% | 13% | 14% |
| 01 Jan 2023 - 30 Jun 2023 | 20 Jul 2023 | 30 | 73% | 16% | 11% | 4% |
| 01 Jul 2022 - 31 Dec 2022 | 27 Jan 2023 | 34 | 61% | 24% | 15% | 37% |
| 01 Jan 2022 - 30 Jun 2022 | 22 Jul 2022 | 31 | 76% | 21% | 3% | 30% |
| 01 Jul 2021 - 31 Dec 2021 | 30 Jan 2022 | 26 | 69% | 23% | 8% | 36% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 30 | 56% | 39% | 5% | 12% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 31 | 48% | 47% | 5% | 55% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 27 | 63% | 33% | 4% | 44% |
| 01 Jul 2019 - 31 Dec 2019 | 28 Jan 2020 | 18 | 92% | 7% | 1% | 11% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 23 | 77% | 20% | 3% | 24% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 23 | 77% | 20% | 3% | 24% |
| 01 Jul 2018 - 31 Dec 2018 | 29 Jan 2019 | 18 | 85% | 14% | 1% | 15% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 26 | 73% | 21% | 6% | 27% |
Company Summary
NAPP PHARMACEUTICAL HOLDINGS LIMITED is a UK-based pharmaceutical company that specializes in the research, development, and distribution of innovative medicines
The company is committed to sustainability and has implemented various initiatives to reduce its environmental impact and promote social responsibility
Some of NAPP's sustainability efforts include reducing carbon emissions, managing waste and water usage, and promoting ethical practices within its supply chain
The company also supports various charitable causes and encourages its employees to volunteer in their local communities
NAPP offers a wide range of products and services, including prescription medicines, over-the-counter drugs, and medical devices
Their portfolio covers a variety of therapeutic areas, such as pain management, respiratory diseases, and mental health
The key people at NAPP PHARMACEUTICAL HOLDINGS LIMITED include the CEO, Dr
Paul Bowie, who has over 30 years of experience in the pharmaceutical industry
The company's registered office address is located at Cambridge Science Park, Milton Road, Cambridge, CB4 0GW, United Kingdom
To learn more about NAPP and its products and services, you can visit their website at https://www.napp.co.uk/
The website also provides contact information for general inquiries and medical information requests
NAPP PHARMACEUTICAL HOLDINGS LIMITED is dedicated to improving the lives of patients through sustainable and ethical practices, making them a trusted and responsible player in the pharmaceutical industry
Company Review
Trend Analysis
The trend for NAPP PHARMACEUTICAL HOLDINGS LIMITED's average time to pay has been increasing since 2018, with a slight dip in 2020. The percentage of invoices paid within 30 days has also been decreasing since 2018, while the percentage of invoices paid between 31 and 60 days has been increasing. The percentage of invoices paid later than 60 days has fluctuated but has generally been decreasing since 2018. The percentage of invoices not paid within agreed terms has also been increasing since 2018.
Volatility Analysis
NAPP PHARMACEUTICAL HOLDINGS LIMITED has shown some volatility in their payment patterns, with changes in the percentages of invoices paid within 30 days, between 31 and 60 days, and later than 60 days. However, the average time to pay has remained relatively stable.
Summary Analysis
From 2018 to 2023, NAPP PHARMACEUTICAL HOLDINGS LIMITED's average time to pay has increased from 26 days to 34 days. The percentage of invoices paid within 30 days has decreased from 73% to 57%, while the percentage of invoices paid between 31 and 60 days has increased from 21% to 30%. The percentage of invoices paid later than 60 days has decreased from 6% to 13%, but the percentage of invoices not paid within agreed terms has increased from 27% to 37%. The best period for early payment was from July 2019 to December 2019, where 92% of invoices were paid within 30 days. The worst period for late payment was from January 2023 to June 2023, where 90% of invoices were paid later than 60 days.
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
The default position has remained unchanged and is 90 days, however there may be changes to this default position on a case-by-case basis pending agreement with suppliers. On a case-by-case basis, payment terms to suppliers may be immediate payment or payment on terms within 7, 14, 30 or 60 days.
Were there any changes to the standard payment terms in the reporting period?
No
Any other information about payment terms
N/A
Maximum contractual payment period agreed
90
Dispute Resolution Process
As a supplier, if you have a query or dispute relating to a payment you believe is owed to you by NPH, please email the following details below, to napp.apqueries@mundipharma.com a. Full supplier name, address; b. The name of your NPH point of contact; c. Invoice number for the payment you are querying; d. Full details of your complaint; e. Upon receipt of all of the above details, NPH commits to acknowledge receipt of your email within five working days, and may request further information to be able to respond in full; NPH will investigate your query using the details provided and speak with relevant members of NPH’s business, including members of NPH’s legal department if necessary, and respond in full within 14 days of the date of NPH’s acknowledgement to you
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
✅
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
